• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《糖尿病与心脏病:糖尿病危险因素管理的循证指南》

Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.

作者信息

Lteif Amale A, Mather Kieren J, Clark Charles M

机构信息

Indiana University School of Medicine, Indianapolis, IN 46202, USA.

出版信息

Cardiol Rev. 2003 Sep-Oct;11(5):262-74. doi: 10.1097/01.crd.0000086892.07437.05.

DOI:10.1097/01.crd.0000086892.07437.05
PMID:12943604
Abstract

Type 2 diabetes is a worldwide epidemic. Cardiovascular diseases remain the major cause of death in patients with diabetes, partly because of the association of diabetes and the metabolic syndrome. In this review, we will discuss the evidence for treatment and prevention of cardiovascular diseases in patients with diabetes. Aggressive treatment of hypertension and dyslipidemia is at the cornerstone in the management of heart disease in those patients. Despite its known benefit on the prevention of the microvascular complications of diabetes, intensive glycemic control may or may not have a significant effect on reducing macrovascular diseases. Finally, lifestyle changes and other cardiovascular therapies aimed at preventing heart disease may also prevent or delay the development of diabetes.

摘要

2型糖尿病是一种全球性的流行病。心血管疾病仍然是糖尿病患者的主要死因,部分原因是糖尿病与代谢综合征相关。在本综述中,我们将讨论糖尿病患者心血管疾病治疗和预防的证据。积极治疗高血压和血脂异常是这些患者心脏病管理的基石。尽管强化血糖控制对预防糖尿病微血管并发症有已知益处,但它对减少大血管疾病可能有显著影响,也可能没有。最后,旨在预防心脏病的生活方式改变和其他心血管治疗也可能预防或延缓糖尿病的发生。

相似文献

1
Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes.《糖尿病与心脏病:糖尿病危险因素管理的循证指南》
Cardiol Rev. 2003 Sep-Oct;11(5):262-74. doi: 10.1097/01.crd.0000086892.07437.05.
2
Treatment of metabolic syndrome.代谢综合征的治疗。
Expert Rev Cardiovasc Ther. 2004 Mar;2(2):213-28. doi: 10.1586/14779072.2.2.213.
3
Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.胰岛素抵抗、糖尿病与心血管风险:治疗方法
Diabetes Obes Metab. 2005 Nov;7(6):642-53. doi: 10.1111/j.1463-1326.2004.00446.x.
4
Statin therapy for the treatment of diabetic dyslipidemia.他汀类药物治疗糖尿病血脂异常
Diabetes Metab Res Rev. 2003 Jul-Aug;19(4):280-7. doi: 10.1002/dmrr.393.
5
Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.了解2型糖尿病及相关心血管疾病:由胰岛素抵抗关联
Am J Manag Care. 2002 Oct;8(16 Suppl):S450-9.
6
Basic approach to managing hyperglycemia for the nonendocrinologist.非内分泌科医生管理高血糖的基本方法。
Am J Cardiol. 2005 Aug 22;96(4A):37E-40E. doi: 10.1016/j.amjcard.2005.06.003.
7
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.与主要内分泌疾病相关的继发性糖尿病:新治疗模式的影响
Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26.
8
Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).2型糖尿病合并冠心病患者的危险因素控制:来自瑞典国家糖尿病登记处(NDR)的研究结果
Diabet Med. 2009 Jan;26(1):53-60. doi: 10.1111/j.1464-5491.2008.02633.x.
9
Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.2型糖尿病的当前治疗方法:成功与不足
Am J Manag Care. 2002 Oct;8(16 Suppl):S460-71.
10
Improving the pharmacological regimen for patients with diabetes mellitus.改善糖尿病患者的药物治疗方案。
Rev Cardiovasc Med. 2004 Summer;5(3):139-47.

引用本文的文献

1
Knockdown of hypoxia-inducible factor 1-alpha (HIF1α) interferes with angiopoietin-like protein 2 (ANGPTL2) to attenuate high glucose-triggered hypoxia/reoxygenation injury in cardiomyocytes.敲低低氧诱导因子 1-α(HIF1α)干扰血管生成素样蛋白 2(ANGPTL2),以减轻心肌细胞高糖诱导的缺氧/复氧损伤。
Bioengineered. 2022 Jan;13(1):1476-1490. doi: 10.1080/21655979.2021.2019874.
2
Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity.糖尿病可能通过降低神经可塑性诱发心血管疾病。
Funct Neurol. 2014 Jan-Mar;29(1):7-13.
3
Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.
心肌脂肪甘油三酯脂肪酶过表达可保护糖尿病小鼠免于发生脂毒性心肌病。
Diabetes. 2013 May;62(5):1464-77. doi: 10.2337/db12-0927. Epub 2013 Jan 24.
4
[Heart failure in diabetes].[糖尿病中的心力衰竭]
Wien Med Wochenschr. 2009;159(5-6):134-40. doi: 10.1007/s10354-009-0645-0.
5
Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3.二甲双胍通过依赖和不依赖半胱天冬酶 - 3的途径影响心肌细胞死亡。
Diabetologia. 2006 Sep;49(9):2174-84. doi: 10.1007/s00125-006-0338-9. Epub 2006 Jul 26.